Dual Antithrombotic Therapy in Atrial Fibrillation Patients undergoing Percutaneous Coronary Angioplasty: The Impact of Bleeding Risk Score on Outcome

被引：0
|
作者：
Aznaouridis, Konstantinos [1 ]
Tselegkidi, Maria-Eirini [2 ]
Kanakakis, Ioannis [2 ]
Alexopoulos, Dimitrios [3 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Hippokrat Hosp, Dept Cardiol 1, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Sch Med, Attikon Univ Hosp, Dept Cardiol 2, Athens, Greece
来源：
THROMBOSIS AND HAEMOSTASIS | 2021年 / 121卷 / 06期
关键词：
INTERVENTION;
D O I：
10.1055/s-0040-1721777
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：845 / 847
页数：3
相关论文
共 50 条
  • [21] The influence of sarcopenia on bleeding risk in patients with atrial fibrillation undergoing coronary stenting and subsequent triple antithrombotic therapy
    Tsuchida, K.
    Nishida, K.
    Tanaka, K.
    Akiyama, T.
    Hakamata, T.
    Sudo, K.
    Hosaka, Y.
    Takahashi, K.
    Oda, H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 454 - 455
  • [22] Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Panov, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (04) : 628 - 637
  • [23] Antithrombotic Strategies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Pan, Daorong
    Ren, Xiaomin
    Hu, Zuoying
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (04) : 496 - 510
  • [24] Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Rajagopalan B.
    Madias C.
    Current Treatment Options in Cardiovascular Medicine, 2019, 21 (1)
  • [25] The Antithrombotic Treatment of Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Bezzina, E.
    Bucci, C.
    Diamantouros, A.
    Radhakrishnan, S.
    Ahmed, S.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2019, 72 (01): : 77 - 77
  • [26] Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Where Are We Now?
    D'Angelo, Ryan G.
    McGiness, Thaddeus
    Waite, Laura H.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (09) : 884 - 897
  • [27] Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Kuno, Toshiki
    Ueyama, Hiroki
    Takagi, Hisato
    Ando, Tomo
    Numasawa, Yohei
    Briasoulis, Alexandros
    Fox, John
    Bangalore, Sripal
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (04): : 521 - 527
  • [28] Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Batra, Gorav
    Friberg, Leif
    Erlinge, David
    James, Stefan
    Jernberg, Tomas
    Svennblad, Bodil
    Wallentin, Lars
    Oldgren, Jonas
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2018, 4 (01) : 36 - 45
  • [29] Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Saito, Yuichi
    Kobayashi, Yoshio
    JOURNAL OF CARDIOLOGY, 2019, 73 (1-2) : 1 - 6
  • [30] Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Sulzgruber, Patrick
    Hofer, Felix
    Kazem, Niema
    Hammer, Andreas
    Niessner, Alexander
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (04) : 875 - 876
12345